Astra said its experimental drug Baxdrostat reduced the blood pressure of patients who have a treatment-resistant form of ...

"Baxdrostat BaxHTN Phase III trials on patients with uncontrolled or treatment-resistant hypertension demonstrated a statistically significant and clinically meaningful reduction in mean-seated ...

Patients in a late-stage trial received one of two different doses of Baxdrostat or a placebo drug once a day, the drugmaker ...

AI is fundamental to the competitive strategies of the most advanced healthcare and pharmaceutical firms. Here is how they ...